Research and development expenses
First written in FY2017-Q2. 24 of 25 entries say "Restated". Latest entry: FY2027-H1.
9 other companies' latest entry also says "Restated".
- FY2027-H1RestatedAnnual report
「R&D expense for the six-month period was ¥24 million. There were no material changes in the status of the Group's R&D activities during the six-month period.」
R&D expense of ¥24 million was disclosed, with no material changes in the status of R&D activities. - FY2026RestatedAnnual report
「R&D expense for the fiscal year was ¥53 million.」
Product development continued, and full-year R&D expense was disclosed as ¥53 million. - FY2026-H1RestatedAnnual report
「R&D expense for the six-month period was ¥25 million. There were no material changes in the status of the Group's R&D activities during the six-month period.」
R&D expense of ¥25 million was disclosed, with no material changes in the status of R&D activities. - FY2024-Q3RestatedAnnual report
「R&D expense for the cumulative third quarter was ¥30 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter.」
R&D expenses of ¥30 million were recorded, and the company stated that there were no material changes in its R&D activities. - FY2024-Q2RestatedAnnual report
「R&D expense for the cumulative second quarter was ¥20 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter.」
R&D expense was disclosed as ¥20 million, with no material changes in the status of R&D activities. - FY2024-Q1RestatedAnnual report
「R&D expense for the cumulative first quarter was ¥10 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter.」
R&D expenses of ¥10 million were recorded, and the company stated that there were no material changes in the status of its R&D activities. - FY2023RestatedAnnual report
「R&D expense for the fiscal year was ¥49 million.」
R&D activities continued, and full-year R&D expense was disclosed as ¥49 million. - FY2023-Q3RestatedAnnual report
「R&D expense for the cumulative third quarter was ¥31 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter.」
Reports ¥31 million in R&D expenses and states that there were no material changes in the status of the Company's R&D activities. - FY2023-Q1RestatedAnnual report
「R&D expense for the cumulative first quarter was ¥8 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter.」
The cumulative first-quarter R&D expense was disclosed as ¥8 million, with no material changes in R&D activities. - FY2022-Q2RestatedAnnual report
「R&D expense for the cumulative second quarter was ¥19 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter.」
R&D expenses of ¥19 million were disclosed, with no significant changes in R&D activities. - FY2021RestatedAnnual report
「R&D expense for the fiscal year was ¥46.309 million.」
Full-year R&D expense was disclosed as ¥46.309 million. - FY2021-Q2RestatedAnnual report
「R&D expense for the cumulative second quarter was ¥19 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter.」
R&D expense of ¥19 million was recorded, with no material changes in R&D activities. - FY2021-Q1RestatedAnnual report
「R&D expense for the cumulative first quarter was ¥10 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter.」
R&D expense of ¥10 million was disclosed, with no material changes in R&D activities. - FY2020-Q2RestatedAnnual report
「R&D expense for the cumulative second quarter was ¥27 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter.」
R&D expense of ¥27 million was disclosed, with no material changes in the status of R&D activities. - FY2020-Q1RestatedAnnual report
「R&D expense for the cumulative first quarter was ¥11 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter.」
R&D expense was disclosed as ¥11 million, with no material changes in the status of R&D activities. - FY2019-Q3RestatedAnnual report
「Research and development expenses for the cumulative third quarter of the current consolidated fiscal year totaled ¥43 million. There were no material changes in the status of the Group’s research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
The cumulative R&D expense for the third quarter was disclosed as ¥43 million, with no material changes in R&D activities. - FY2019-Q2RestatedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year totaled ¥28 million. There were no material changes in the status of the Group’s research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
Research and development expenses were disclosed as ¥28 million, with no material changes reported in research and development activities. - FY2019-Q1RestatedAnnual report
「Research and development expenses for the cumulative first quarter of the current consolidated fiscal year totaled ¥15 million. There were no material changes in the status of the Group’s research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
Research and development expenses were disclosed as ¥15 million, with no material changes reported in the status of research and development activities. - FY2018RestatedAnnual report
「Research and development expenses for the current consolidated fiscal year totaled ¥66.335 million.」
Full-year research and development expenses were disclosed as ¥66.335 million. - FY2018-Q3RestatedAnnual report
「Research and development expenses for the cumulative third quarter of the current consolidated fiscal year totaled ¥46 million. There were no material changes in the status of the Group’s research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
Research and development expenses were disclosed as ¥46 million, with no material changes reported in the status of research and development activities. - FY2018-Q2RestatedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year totaled ¥31 million. There were no material changes in the status of the Group’s research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
Research and development expenses were disclosed as ¥31 million, with no material changes reported in the status of research and development activities. - FY2018-Q1RestatedAnnual report
「Research and development expenses for the cumulative first quarter of the current consolidated fiscal year totaled ¥13 million. There were no material changes in the status of the Group’s research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
Research and development expenses were disclosed as ¥13 million, with no material changes reported in the status of research and development activities. - FY2017RestatedAnnual report
「Research and development expenses for the current consolidated fiscal year totaled ¥56.423 million.」
Full-year research and development expenses were disclosed as ¥56.423 million. - FY2017-Q3RestatedAnnual report
「Research and development expenses for the cumulative third quarter of the current consolidated fiscal year totaled ¥40 million. There were no material changes in the status of the Group’s research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
Research and development expenses were disclosed as ¥40 million, with no material changes reported in the status of research and development activities. - FY2017-Q2First statedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year totaled ¥28 million. There were no material changes in the status of the Group’s research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
Research and development expenses for the cumulative second quarter were disclosed as ¥28 million, with no material changes reported in research and development activities.